What Is B6-13 and Why the Confusion?
B6-13 is an informal label sometimes used online to refer to a supposed 13th distinct form of vitamin B6. In strict biochemical terms, vitamin B6 comprises a family of six chemically related vitamers that function as cofactors in amino acid metabolism: pyridoxine, pyridoxamine, pyridoxal, and their phosphorylated derivatives (pyridoxine 5′-phosphate, pyridoxamine 5′-phosphate, and pyridoxal 5′-phosphate). No recognized, independent B6-13 form appears in authoritative biochemical references. This article clarifies the origin of the term, reviews the established B6 vitamers, and explains why B6-13 is best treated as a mislabel rather than a verified nutrient entity.
Established Vitamin B6 Vitamers
Vitamin B6 activity resides in multiple interconvertible forms found in foods, supplements, and human tissues. The main vitamers and their roles are outlined below.
Pyridoxine and Its Phosphorylated Form
Pyridoxine is the primary form found in plants and supplements. In cells it is rapidly converted to pyridoxine 5′-phosphate (PLP), the major circulating and enzymatically active cofactor in humans.
Pyridoxamine and Its Phosphorylated Form
Pyridoxamine arises from certain foods and can be metabolized to pyridoxamine 5′-phosphate, another active cofactor involved in glycation regulation.
Pyridoxal and Its Phosphorylated Form
Pyridoxal is produced during catabolism and converted to pyridoxal 5′-phosphate, which functions alongside PLP in numerous transamination and decarboxylation reactions.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Core vitamers | Pyridoxine, pyridoxamine, pyridoxal, and respective 5′-phosphates | Biochemistry consensus and IOM/EFSA reports |
| Active coenzyme form | Pyridoxal 5′-phosphate (PLP) | Enzyme cofactor literature |
| Dietary sources | Poultry, fish, potatoes, bananas, fortified cereals | USDA nutrient database |
| Recommended intake (adults) | 1.3–1.7 mg/day pyridoxine equivalents | EFSA and NIH guidelines |
Origins of the B6-13 Label
Online discussions sometimes invent numeric extensions like B6-13 to dramatize minor variants, marketing claims, or misread patent documents. These references typically lack peer-reviewed characterization, standardized nomenclature, or evidence of distinct pharmacology. Unlike the six established B6 vitamers, B6-13 is not cataloged in IUPAC/IUBMB nomenclature, major spectral databases, or regulatory ingredient lists.
How B6-13 Differs From True B6 Vitamers
Because B6-13 is not a substantiated entity, meaningful biochemical comparisons are not possible. In contrast, the six known B6 vitamers are interconvertible in vivo, share the same 4-pyridoxyl ring core, and are recognized by common transaminase and oxidoreductase machinery. Their differences lie in side-chain modifications (e.g., methyl, hydroxymethyl, amino groups) that influence tissue distribution, enzyme affinity, and metabolic fate, but all culminate in PLP-dependent chemistry.
Current Evidence and Regulatory Status
Regulatory agencies recognize only the established B6 vitamers when setting intake recommendations, labeling requirements, and safety thresholds. No dossier supports a discrete B6-13 molecule with validated bioavailability, toxicity, or efficacy. Until reproducible analytical and clinical data emerge, B6-13 should be treated as a conceptual placeholder rather than a defined nutrient.
Practical Guidance for Consumers and Professionals
For individuals evaluating products that mention B6-13, rely on verified information about known B6 vitamers. Look for labels that specify pyridoxine hydrochloride, pyridoxal-5′-phosphate, or pyridoxamine-5′-phosphate, and consult authoritative sources such as government RDAs and professional society statements. Prioritize formulations backed by peer-reviewed research rather than unverified extensions of established vitamin nomenclature.